Pluripotent Stem Cells & Neurotransmitter is a Breast Cancer Game changer for pain.

Pluripotent Stem Cells & Neurotransmitter is a Breast Cancer Game changer for pain.

Hybrid Medical Analytics research focuses on identifying the cause of chronic pain an ion pump dysfunction in the nervous system that disrupts neurotransmitter signaling.

Breast Cancer pain as an unpleasant sensory and emotional experience associated with actual or potential tissue damage, Breast Cancer pain can be managed effectively through relatively simple means in up to 90% of Breast Cancer Patients.

Identifying the etiology of pain is important to its management.

Neurotransmitters is showing Promise. billions of neurons in the mammalian brain communicate with each other with liberating chemical messengers that are detected by receptors on adjacent cells.

These chemical messengers, or neurotransmitters, can be ions, amino acids, amino acid derivatives, or large polypeptides.

Gene targeting in embryonic stem cells to generate dopamine-deficient .
Gene targeting in embryonic Pluripotent Stem Cell can be the अन्स्वेर




Hybrid Medical Analytics Area of Research

* Breast cancer
* Endocrine system cancer
* Gastrointestinal cancer
* Genitourinary cancer
* Gynaecological cancer
* Haematological cancer
* Head and neck cancer
* Neurooncology
* Paediatric oncology
* Thoracic oncology
* Sarcoma
* Skin cancer
* Epidemiology, cancer prevention, and cancer control
* Supportive care
* Imaging
* Health-care systems